Company News

Semex is pleased to announce its 2022-2023 Board of Directors with one new member, Jean Bissonnette, joining the Board, replacing outgoing director Mariette Gagnon, representing Centre d'insémination artificielle du Québec (CIAQ).

Phil MacLean will continue to serve as President of the Board (EastGen), assisted by Vice President Jean-François Morin (CIAQ) and Executive Member Curtis McNeil (EastGen). Other members of the Board of Directors include: Normand Barriault (CIAQ); Richard Lagacé (CIAQ); Gerrit Wensink (EastGen); Jean Bissonnette (CIAQ); Tom Pasco (EastGen); and James Ross (WestGen); Tony Van Garderen (WestGen).

Semex is comprised of three Owners: WestGen, CIAQ (Centre d'insémination artificielle du Québec) and EastGen. As a leading global genetics company, Semex is focused on providing our clients with the solutions, innovations and technologies that positively impact their lives, as well as the lives of the animals on their operations and within our global community. This is Genetics for Life, our guiding compass.

Photo Caption: Top from L to R: Phil MacLean, Jean-François Morin, Curtis McNeil; Middle from L to R: Normand Barriault, Jean Bissonnette, Tony Van Garderen; Bottom from L to R: Richard Lagacé, Gerrit Wensink, Tom Pasco, James Ross.